The latest news & stories from the Providence Research Network

  • Unlocking the promise of PGx: Insights from CORE

    Unlocking the promise of PGx: Insights from CORE

    Research and an environmental scan by the Center for Outcomes Research & Education (CORE) offer key lessons for healthcare leaders working to advance Pharmacogenetic screenings in healthcare settings.

    Read Article
  • A new generation CDK4 inhibitor study for people with HR+ HER2- breast cancer

    A new generation CDK4 inhibitor study for people with HR+ HER2- breast cancer

    A phase III clinical trial for people with HR+ HER2- breast cancer aims to extend survival and improve patients’ quality of life.

    Read Article
  • New Study: Providence whole genome sequencing program shows transformative potential for population health

    New Study: Providence whole genome sequencing program shows transformative potential for population health

    Published in Nature NPJ Genomic Medicine, Providence-led Geno4ME research program study highlights early detection, personalized prevention and prospect of improved care outcomes.

    Read Article
  • CORE study offers new data on Medicaid health-related housing benefits

    CORE study offers new data on Medicaid health-related housing benefits

    Recognizing the links between housing and health, Medicaid programs are testing new housing benefit programs. Research by Providence CORE published in JAMA offers valuable insights for these efforts.

    Read Article
  • Advancing personalized treatments for gliomas at Providence Brain & Spine Institute

    Advancing personalized treatments for gliomas at Providence Brain & Spine Institute

    For decades, brain cancer has remained one of the most difficult forms of cancer to treat. A new wave of research and advances in personalized treatments are bringing new hope.

    Read Article
  • New Horizons in Immunotherapy for Cancer symposium: Collaborative cancer research

    New Horizons in Immunotherapy for Cancer symposium: Collaborative cancer research

    Expert voices in immuno-oncology from inside and outside Providence gather for a day of thought-provoking discussion, discovery and collaboration.

    Read Article
  • Providence researchers share cancer discoveries at 2025 ASCO meeting

    Providence researchers share cancer discoveries at 2025 ASCO meeting

    Explore new findings in cancer immunotherapy and clinical research from Providence at ASCO 2025.

    Read Article
  • Providence sees dramatic rise in goals of care conversations after implementing system-wide changes

    Providence sees dramatic rise in goals of care conversations after implementing system-wide changes

    Providence documented and tracked more than 8,500 goals of care conversations in its electronic health record for critical care patients in 2024.

    Read Article
  • Personalized mRNA vaccine and next-gen immunotherapy: Two new cancer trials at Providence

    Personalized mRNA vaccine and next-gen immunotherapy: Two new cancer trials at Providence

    Providence Cancer Institute is enrolling patients for two new immunotherapy trials targeting muscle-invasive urothelial cancer and advanced solid tumors.

    Read Article
  • Clinical trials matter, just ask Randy

    Clinical trials matter, just ask Randy

    When Randy was diagnosed with small cell lung cancer, he thought it was time to get his affairs in order. But a phase I clinical trial at Providence Cancer Institute gave him more time and hope.

    Read Article
  • Striking disparities in off-label GLP-1 prescribing revealed by study co-authored at Providence

    Striking disparities in off-label GLP-1 prescribing revealed by study co-authored at Providence

    Research co-authored by Providence CARDS found striking disparities in off-label prescribing of the popular GLP1-RA medications initially FDA-approved for diabetes and more recently for weight loss

    Read Article
  • Seeking better treatments for people with ER+/HER- breast cancer

    Seeking better treatments for people with ER+/HER- breast cancer

    Two studies for people with ER+/HER2- breast cancer are enrolling patients at Providence Cancer Institute.

    Read Article
  • Studies to be presented by Providence researchers at AACR annual meeting

    Studies to be presented by Providence researchers at AACR annual meeting

    The annual AACR meeting draws the most innovative cancer researchers seeking breakthroughs in treatments.

    Read Article
  • CORE's 2024 annual report

    CORE's 2024 annual report

    CORE's annual report highlights some of the impactful and promising research, programs, and partnerships that we supported last year.

    Read Article
  • Ted Lowenkopf, M.D., medical director of Providence St. Vincent Stroke Center, retires

    Ted Lowenkopf, M.D., medical director of Providence St. Vincent Stroke Center, retires

    Read about Dr. Lowenkopf’s storied 25-year career and his transformative work in stroke care, plus a personal message from Dr. Lowenkopf.

    Read Article
  • Robotic versus open surgery for early cervical cancer

    Robotic versus open surgery for early cervical cancer

    This is an exciting new trial comparing robotic assisted laparoscopy to open hysterectomy and lymph node assessment for the treatment of early-stage cervical cancer.

    Read Article
  • CORE: Supporting community-driven change for older adults

    CORE: Supporting community-driven change for older adults

    The Advancing Health Equity in Aging initiative aims to address disparities faced by older adults by harnessing interventions directly from their communities.  As the initiative's collaborative learni

    Read Article
  • Leading US health systems launch the Truveta Genome Project, creating the world’s largest and most diverse database to discover the science

    Leading US health systems launch the Truveta Genome Project, creating the world’s largest and most diverse database to discover the science

    The Truveta Genome Project will enable scientists to transform how diseases are prevented, diagnosed and cured.

    Read Article
  • CORE selected to evaluate Oregon's ContraceptiveCare program

    CORE selected to evaluate Oregon's ContraceptiveCare program

    The Oregon Health Authority has selected Providence CORE to evaluate the next phase of Oregon's ContraceptiveCare (CCare) program.

    Read Article
  • CAR T cell-therapy, hope and healing: Dean’s story

    CAR T cell-therapy, hope and healing: Dean’s story

    Discover how Dean Lookingbill’s battle with lymphoma led him to CAR T-cell therapy at Providence Cancer Institute.

    Read Article
  • loading
    Loading More...